The Spectator

‘We are all going to live longer, so why not invest in it?’­ seems to be the premise of Jim Mellon and Al Chalabi’s new book, Juvenescence – Investing in the Age of Longevity. Mellon and Chalabi forecast that within the next 20 years, the average life expectancy in the developed world will rise to between 110 and 120…

In their book, Mellon and Chalabi discuss all sorts of questions, from whether ageing is actually a disease, to whether it can be slowed, reversed or eliminated.